Enhancing Sleep Duration: Effects on Children's Eating and Activity Behaviors-Renewal
Status: | Recruiting |
---|---|
Conditions: | Insomnia Sleep Studies, Obesity Weight Loss |
Therapuetic Areas: | Endocrinology, Psychiatry / Psychology |
Healthy: | No |
Age Range: | 8 - 11 |
Updated: | 4/17/2018 |
Start Date: | March 1, 2018 |
End Date: | June 30, 2022 |
Contact: | Ashley Greer, MPH |
Email: | ashley.greer@temple.edu |
Phone: | 215-707-8998 |
Enhancing children's sleep may be a novel approach for prevention of obesity and
cardiovascular (CV) disturbance. Observational studies with children demonstrate that short
sleep increases risk of obesity and other CV risk factors. Randomized controlled trials with
children 8-11 years old demonstrate that enhancing sleep duration leads to positive changes
in eating and activity behaviors and weight status, particularly for children who enhance
their sleep the most. Enhancing sleep may be particularly important for racial minority
children and those from lower socioeconomic backgrounds given their increased risk for short
sleep, obesity and CV risk factors. In this study two active obesity preventive interventions
will be evaluated: a) enhancing sleep alone (Optimize Sleep [OS]), and b) enhancing sleep
along with eating and activity behaviors that have demonstrated efficacy for obesity
prevention and are implicated in self-regulatory pathways related to sleep (i.e., energy
dense snack foods and beverages, TV viewing, and physical activity) (OS-Plus). Two hundred
four children 8-11 years old who are African American/black, primarily from low socioeconomic
backgrounds, and who sleep < 9.5 hours/night into a 12-month study will be enrolled. Children
will be randomly assigned to either OS or OS-Plus. Over the 6-month treatment phase, all
children will attend an 8-session treatment; monthly phone contacts will occur during
maintenance (6-12 months). Primary aim is to determine the efficacy of OS-Plus relative to OS
on change in body mass index z-score (BMIz) at end of treatment. Secondary aims will assess
efficacy of OS-Plus relative to OS on additional cardiometabolic risk factors, eating and
activity behaviors. Exploratory aims will assess maintenance of effects at 12 months.
cardiovascular (CV) disturbance. Observational studies with children demonstrate that short
sleep increases risk of obesity and other CV risk factors. Randomized controlled trials with
children 8-11 years old demonstrate that enhancing sleep duration leads to positive changes
in eating and activity behaviors and weight status, particularly for children who enhance
their sleep the most. Enhancing sleep may be particularly important for racial minority
children and those from lower socioeconomic backgrounds given their increased risk for short
sleep, obesity and CV risk factors. In this study two active obesity preventive interventions
will be evaluated: a) enhancing sleep alone (Optimize Sleep [OS]), and b) enhancing sleep
along with eating and activity behaviors that have demonstrated efficacy for obesity
prevention and are implicated in self-regulatory pathways related to sleep (i.e., energy
dense snack foods and beverages, TV viewing, and physical activity) (OS-Plus). Two hundred
four children 8-11 years old who are African American/black, primarily from low socioeconomic
backgrounds, and who sleep < 9.5 hours/night into a 12-month study will be enrolled. Children
will be randomly assigned to either OS or OS-Plus. Over the 6-month treatment phase, all
children will attend an 8-session treatment; monthly phone contacts will occur during
maintenance (6-12 months). Primary aim is to determine the efficacy of OS-Plus relative to OS
on change in body mass index z-score (BMIz) at end of treatment. Secondary aims will assess
efficacy of OS-Plus relative to OS on additional cardiometabolic risk factors, eating and
activity behaviors. Exploratory aims will assess maintenance of effects at 12 months.
Inclusion Criteria:
1. Caregiver-reported child age of 8-11 years
2. < 9.5 Hours time-in-bed for sleep most days/week
3. Self-reported race as African-American/Black
4. BMI for age and gender > 10th percentile (but no greater than 100% overweight)
5. Understanding of and ability to complete protocol
6. Self-reported caregiver age of 18 years and primary caregiver at bedtimes/wake times
7. Likes food used in the eating regulation paradigms
8. Willingness to be randomized to either treatment condition.
Exclusion Criteria:
1. Diagnosable sleep disorder
2. Medication use or diagnosis of medical or psychiatric condition that may impact
sleep/weight status
3. Current or planned treatment for weight control
4. Allergies or dietary restrictions that would prevent consumption of foods used in the
study
We found this trial at
1
site
1801 N Broad St
Philadelphia, Pennsylvania 19122
Philadelphia, Pennsylvania 19122
(215) 204-7000
Phone: 215-707-5782
Temple University Temple University is many things to many people. A place to pursue life's...
Click here to add this to my saved trials